CLINICAL TRIALS PROFILE FOR PROTONIX IV
✉ Email this page to a colleague
All Clinical Trials for PROTONIX IV
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00133770 ↗ | Intravenous (IV) Pantoprazole in Erosive Esophagitis | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 | 2004-07-01 | The aim of this study is to examine whether pantoprazole (Protonix) given through continuous intravenous infusion for 72 hours is superior to Protonix given through once a day IV injection in the treatment of erosive esophagitis. |
NCT00133770 ↗ | Intravenous (IV) Pantoprazole in Erosive Esophagitis | Completed | Emory University | Phase 4 | 2004-07-01 | The aim of this study is to examine whether pantoprazole (Protonix) given through continuous intravenous infusion for 72 hours is superior to Protonix given through once a day IV injection in the treatment of erosive esophagitis. |
NCT00206050 ↗ | Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po | Completed | AstraZeneca | Phase 4 | 2004-09-01 | This Phase IV study is intended to compare intragastric acid suppression of oral esomeprazole (NEXIUM ® Delayed-Release Capsules) with that of oral pantoprazole (PROTONIX ® Delayed Release Tablets ), in subjects who continue to require acid-suppressive therapy following a course of intravenous (iv) pantoprazole (PROTONIX ® I.V. for Injection). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PROTONIX IV
Condition Name
Clinical Trial Locations for PROTONIX IV
Trials by Country
Clinical Trial Progress for PROTONIX IV
Clinical Trial Phase
Clinical Trial Sponsors for PROTONIX IV
Sponsor Name